Index of reports
> Cases with Ear Infection (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Leukeran (Chlorambucil) where reactions include ear infection. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Leukeran side effects in 61 year old female
Reported by a individual with unspecified qualification from Ukraine on 2012-05-14
Patient: 61 year old female
Reactions: Ear Infection, Respiratory Tract Infection Viral
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituxan
Dosage: (375 mg/m2) intravenous (not otherwise specified)
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2011-10-27
Leukeran
Dosage: (18 mg/m2) intravenous (not otherwise specified)
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2011-10-27
Ofatummab (Ofatummab)
Dosage: intravenous (not otherwise specified)
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2011-12-21
Possible Leukeran side effects in 61 year old female
Reported by a health professional (non-physician/pharmacist) from Ukraine on 2012-05-03
Patient: 61 year old female, weighing 74.0 kg (162.8 pounds)
Reactions: Ear Infection, Respiratory Tract Infection Viral
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ofatumumab (Ofatumumab)
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2011-12-21
Leukeran
Dosage: (18 mg/m2)
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2011-10-27
Rituxan
Dosage: (375 mg/m2)
Indication: Chronic Lymphocytic Leukaemia Refractory
Start date: 2011-10-27
|